Beranda › Kanker Paru Non-Sel Kecil › California

Uji klinis Kanker Paru Non-Sel Kecil di California

207 studi untuk Kanker Paru Non-Sel Kecil mencari peserta di lokasi di California.

Kota di California

Teks studi resmi (Bahasa Inggris)

A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

City of Hope /ID# 243157, Duarte
City Of Hope - Seacliff /ID# 263143, Huntington Beach
City of Hope - Orange County Lennar Foundation Cancer Center /ID# 263144, Irvine
dan 1 lainnya

Menerima pesertaFase 3

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Okt 2026 · NCT04928846

A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Start Los Angeles /ID# 284999, Los Angeles
Valkyrie Clinical Trials /ID# 271322, Los Angeles
FOMAT Medical Research - Clinica mi Salud by Focil Med /ID# 284816, Oxnard

Menerima pesertaFase 2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Okt 2026 · NCT06568939

A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)

CBCC Global Research, Inc. ( Site 0123), Bakersfield
Beverly Hills Cancer Center ( Site 0116), Beverly Hills

Menerima pesertaFase 3

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Okt 2026 · NCT06345729

A Study of ZW251 in Participants With Advanced Solid Tumors

UCSF Comprehensive Cancer Center, San Francisco
University of California Los Angeles - Cancer Care - Santa Monica (UCLA), Santa Monica

Menerima pesertaFase 1

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Okt 2026 · NCT07164313

A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

City of Hope National Medical Center /ID# 277005, Duarte
City of Hope - Orange County Lennar Foundation Cancer Center /ID# 277928, Irvine
UC San Diego Health - Moores Cancer Center /ID# 278836, La Jolla

Menerima pesertaFase 2/3

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Okt 2026 · NCT07155187

Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial

Tower Cancer Research Foundation, Beverly Hills
Cedars-Sinai Medical Center, Los Angeles
Cedars-Sinai Cancer - Tarzana, Tarzana
dan 1 lainnya

Menerima pesertaFase 3

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Okt 2026 · NCT07388524

Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations

Providence - St. Jude Medical Center /ID# 271414, Fullerton
FOMAT Medical Research - Clinica mi Salud by Focil Med /ID# 274450, Oxnard
UCLA - Santa Monica /ID# 271690, Santa Monica

Menerima pesertaFase 1/2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Okt 2026 · NCT06772623

Safety and Efficacy of OBX-115 in Advanced Solid Tumors

The Angeles Clinic and Research Institute (Melanoma), Los Angeles
USC Norris Comprehensive Cancer Center (Melanoma/NSCLC), Los Angeles
Stanford Cancer Institute (Melanoma/NSCLC), Stanford

Menerima pesertaFase 1/2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Okt 2026 · NCT06060613

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Kaiser Permanente-Anaheim, Anaheim
Kaiser Permanente-Deer Valley Medical Center, Antioch
Sutter Auburn Faith Hospital, Auburn
dan 56 lainnya

Menerima pesertaFase 3

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Okt 2026 · NCT04267848

A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment

USC / Norris Comprehensive Cancer Center, Los Angeles

Menerima pesertaFase 2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07293247

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

City of Hope National Medical Center, Duarte
University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla
UCLA Department of Medicine-Hematology/Oncology, Los Angeles

Menerima pesertaFase 1

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06465069

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

University of San Diego Moores Cancer Center, La Jolla
UCLA Jonsson Comprehensive Cancer Center, Los Angeles
USC Norris Comprehensive Cancer Center, Los Angeles

Menerima pesertaFase 1/2

Usia 12 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT04585750

A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

Providence St. Jude Medical Center ( Site 0106), Fullerton
VA Long Beach Healthcare System ( Site 0199), Long Beach
USC Norris Comprehensive Cancer Center ( Site 0205), Los Angeles
dan 2 lainnya

Menerima pesertaFase 3

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06623422

A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.

Los Angeles Cancer Network, Glendale
Providence St. Joseph Hospital, Orange

Menerima pesertaFase 2/3

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07365319

Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor

Clinical Research Advisors, LLC, Beverly Hills

Menerima pesertaFase 3

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06472245

A Platform Study in Non-Small Cell Lung Cancer (NSCLC)

Research Site, Santa Rosa

Menerima pesertaFase 1/2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06996782

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Exelixis Clinical Site #59, Santa Barbara

Menerima pesertaFase 1

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT05176483

A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)

UC Davis Comprehensive Cancer Center ( Site 3204), Sacramento

Menerima pesertaFase 3

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07513376

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

City of Hope, Duarte

Menerima pesertaFase 2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06172478

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Tower Cancer Research Foundation, Beverly Hills
Kaiser Permanente Dublin, Dublin
Kaiser Permanente-Fremont, Fremont
dan 20 lainnya

Menerima pesertaFase 3

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06498635

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

City of Hope Comprehensive Cancer Center, Duarte
University of California Los Angeles, Los Angeles
University of California San Diego Moores Cancer Center, San Diego

Menerima pesertaFase 1

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06625775

A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

City of Hope National Medical Center, Duarte
City of Hope at Irvine Lennar, Irvine
Ronald Reagan UCLA Medical Center, Los Angeles
dan 3 lainnya

Menerima pesertaFase 1

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07090499

Adaptive ctDNA-Based Personalization of Treatment During Consolidation Therapy in NSCLC

Stanford University, Stanford

Menerima pesertaFase 3

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT04585490

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung Cancer

START LA, Los Angeles
Cedars-Sinai Medical Center, Los Angeles
Valkyrie Clinical Trials, Los Angeles

Menerima pesertaFase 2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07659782

A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)

Beverly Hills Cancer Center, Beverly Hills
Orange Coast Memorial Medical Center, Fountain Valley
Local Institution - 0027, Los Alamitos
dan 5 lainnya

Menerima pesertaFase 3

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07361510

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

ALX Center 9, La Jolla
ALX Center 11, Santa Monica

Menerima pesertaFase 1

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07085091

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

Hoag Hospital Newport Beach, Newport Beach
University of California, Irvine Health, Orange

Menerima pesertaFase 3

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT06765109

A Study of PHN-012 in Patients With Advanced Solid Tumors

PHN-012-001 Site, Los Angeles
PHN-012-001 Site, San Diego

Menerima pesertaFase 1

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT07127874

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

Research Site, Duarte
Research Site, Los Angeles
Research Site, Newport Beach
dan 1 lainnya

Menerima pesertaFase 1

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT05877599

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

MemorialCare Long Beach Medical Center, Long Beach

Menerima pesertaFase 3

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT06881784

A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer

University of California at San Diego, La Jolla
University of California Irvine, Orange
Stanford Cancer Institute, Stanford

Menerima pesertaFase 2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT05498428

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

Alta Bates Summit Medical Center Comprehensive Cancer Center, Berkeley
John Muir Health Clinical Research Center, Concord
UC San Diego Medical Center - Encinitas, Encinitas
dan 16 lainnya

Menerima pesertaFase 3

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07144280

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

Beverly Hills Cancer Center ( Site 0070), Beverly Hills
UCLA Clinical & Translational Research Center (CTRC) ( Site 0033), Los Angeles
Hoag Memorial Hospital Presbyterian ( Site 0096), Newport Beach
dan 2 lainnya

Menerima pesertaFase 3

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06312137

Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)

Roy and Patricia Disney Family Cancer Center - Providence Saint Joseph Medical Center ( Site 0130), Burbank

Menerima pesertaFase 3

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06170788

A Study of Neoadjuvant Amivantamab With Either Lazertinib or Chemotherapy in Participants With Resectable EGFR-Mutated NSCLC

City of Hope, Duarte
City of Hope 1, Irvine

Menerima pesertaFase 2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07586202

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

University of California San Diego, La Jolla
Stanford University, Palo Alto
UCLA Medical Center, Santa Monica

Menerima pesertaStudi observasional

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT04981119

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

Sansum Clinic, Santa Barbara

Menerima pesertaFase 3

Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT05920356

A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer

Research Site, La Mesa
Research Site, Los Alamitos

Menerima pesertaFase 3

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06868277

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Oncura Health - Anaheim, Anaheim
Memorial Care Orange Coast Medical Center Attn, Fountain Valley
MemorialCare Orange Coast Medical Center, Fountain Valley
dan 20 lainnya

Menerima pesertaFase 3

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07222566

A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)

Moores Cancer Center at UC San Diego Health, La Jolla

Menerima pesertaFase 2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06667908

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.